News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Nuvisan Pharma Services Selects ALPHADAS To Accelerate Clinical Development Processes


6/12/2014 8:24:36 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

CONSHOHOCKEN, Pa.--(BUSINESS WIRE)--Instem, a leading provider of IT solutions to the global early development healthcare market, announced today that NUVISAN Pharma Services (“NUVISAN”) has purchased the ALPHADAS® clinical trials software solution suite for deployment in its Phase I unit located in Neu-Ulm, Germany.

Help employers find you! Check out all the jobs and post your resume.

Read at BioSpace.com

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES